Atlas Trials

Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant

Clinical trial NCT02506933 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02506933
Sponsor
City of Hope Medical Center
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia in RemissionChronic Lymphocytic LeukemiaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveCytomegaloviral InfectionHodgkin LymphomaLymphadenopathyLymphoblastic LymphomaMyelodysplastic SyndromeMyelofibrosisMyeloproliferative Neoplasm
Start date
2015-12-21
Primary completion
2018-01-25
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.